Goldline Pharmaceutical MD, chairman, board of directors and AGM
BSE: 544759Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.98.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,537th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 9 Jun 2026
- 7.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 9 Jun 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 9 Jun 2026
- 28.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 Jun 2026
- 0.64
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,000
Goldline Pharmaceutical AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Goldline Pharmaceutical share news and announcements
Annual general meeting, 29 Aug 2026
426 shareholders on the register on 22 Aug 2026; present: 4 promoters and 11 others; votes counted by Avinash Gandhewar / M/s. Avinash Gandhewar & Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt the Standalone Audited Balance Sheet for the year ended 31st March, 2026, the Profit and Loss account for the year ended as on the said date, Cash Flow Statement, Auditors' Report and the Directors' Report thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- To declare dividend on preference shares for the financial year 2025-26.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- To re-appoint Mr. Prashant Shrikrishna Karkare, Director (DIN: 06572686) who retires by rotation and being eligible, offers himself for the re- appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- To approve existing as well as new material related party transactions with Activista Healthcare Private LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- To approve existing as well as new material related party transactions with Nucleage Pharma Solutions Private LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- To approve existing as well as new material related party transactions with Numerius Healthcare Private LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- Borrowing of Unsecured Loan from directors with an Option of Convertibility into Equity SharesSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
- Approval of loans, investments, guarantee or security u/s 185 of Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.11% · promoters 100.00% · institutions 0.00% · other public 7.94%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.